Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Actus Nutrition is a specialized medical nutrition brand and business unit of Ajinomoto Cambrooke, dedicated to providing advanced dietary solutions for individuals with rare metabolic disorders. The company is best known for its innovative use of Glycomacropeptide (GMP), a natural whey-derived protein that is phenylalanine-free, offering a superior nutritional profile and taste compared to traditional synthetic amino acid formulas for Phenylketonuria (PKU). Actus Nutrition provides a comprehensive range of medical foods, including ready-to-drink formulas, powders, and low-protein food products designed to support metabolic balance and improve patient compliance. Following its acquisition by the Ajinomoto Group, the company has integrated global amino acid expertise to enhance its product development and expand its therapeutic reach in the orphan disease space. Its mission centers on improving the quality of life for patients who must adhere to strict, lifelong nutritional interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Actus Nutrition.